Completed EARLY_PHASE1 INTERVENTIONAL 4-arm NCT00779909

Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model

Sponsor: Boston University

Updated 8 times since 2017 Last updated: Aug 30, 2017 Started: Dec 31, 2008 Primary completion: May 31, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00779909, this EARLY_PHASE1 trial focuses on Gingivitis and remains completed. Sponsored by Boston University, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Dec 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Dec 2021 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

▶ Show 3 earlier versions

Oct 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: NA → EARLY_PHASE1
Feb 2017 — Oct 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston University
National Center for Complementary and Integrative Health (NCCIH)

Data source: Boston University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States